HES1 in immunity and cancer

Area of Science:

• Molecular Biology
• Cancer Biology
• Cell Signaling

Background:

• Hairy and enhancer of split homolog-1 (HES1) is a basic helix-loop-helix (bHLH) transcription factor crucial for cell cycle, differentiation, and apoptosis.
• HES1 function is regulated by NOTCH, Hedgehog, and Wnt signaling pathways, which are frequently aberrant in cancer.

Purpose of the Study:

• To review the current biology and molecular mechanisms of HES1.
• To explore HES1's role in cancer and its potential as a clinical therapeutic target.

Main Methods:

• Literature review of HES1 biology and cancer-related signaling pathways.
• Analysis of molecular mechanisms linking HES1 to cancer progression, including EMT and cell survival.

Main Results:

• HES1 plays a significant role in regulating cell fate and is involved in various cancers.
• Complex crosstalk exists between HES1 and signaling pathways, impacting immune response and cancer, including leukemia.
• HES1 contributes to tumor invasiveness, metastasis via EMT, and tumor cell survival.

Conclusions:

• HES1 is a key regulator in normal cellular processes and cancer development.
• Understanding HES1's intricate molecular mechanisms and pathway interactions is vital for cancer therapeutics.
• HES1 represents a promising clinical target for novel cancer treatment strategies.